Eligible patients can undergo screenings every year, further increasing the chances of catching lung cancer early. The Lung ...

Researchers Identify Key Mechanism in Human Lung Development Oct ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep.

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

TAIPEI (Taiwan News) — Taiwan has expanded lung cancer screening services, lowering the eligible age for individuals with a ...

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Tarlatamaba, a new treatment for adult patients with SCLC, has been approved by the Medicines and Healthcare Products ...

Lung cancer is the most common cause of cancer death in the UK, and is usually diagnosed late. However, the condition can ...

Blueprint Medicines is cutting funding to its clinical-stage CDK2 inhibitor even as the Ayvakit-maker pushes forward with ...